Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts from ‘April, 2009’

Abraxis BioScience Names Lonnie Moulder President and Chief Executive Officer; Soon-Shiong Remains Executive Chairman

Soon-Shiong to Assume Role as Chairman and CEO for Abraxis Health LOS ANGELES–(HSMN NewsFeed)–Abraxis BioScience, Inc. (NASDAQ:ABII ), a fully integrated biotechnology company, today announced that Leon (Lonnie) O. Moulder, Jr., has been appointed Vic…
Biopharmaceuticals, Personnel
Abraxis BioScience

Bausch and Lomb and 20/10 Consummate Vision Finalize Refractive Surgery Joint Venture

MUNICH, Germany, April 30 (HSMN NewsFeed) — Bausch & Lomb, the global eye health company, and 20/10 Perfect Vision AG, the femtosecond laser developer, have completed their transaction to form a joint venture focused on the laser vision correction indus…
Devices, Ophthalmology
Bausch & Lomb, 20/10 Perfect Vision AG, Technolas Flawless Vision, femtosecond

Cardica Develops the Cardica Microcutter, The First True Multi-Fire Endolinear Cutter

Represents Company’s Planned Expansion Beyond Cardiac Surgery into Other Major Surgical Markets with Large Potential New Form Factor Also Would Be Smallest Available, Enabling Single-Site and Natural Orifice Surgery REDWOOD CITY, Calif., April 30 (H…
Devices, Surgery
Cardica, Cardica Microcutter, endoscopic linear microcutter

Imaging Diagnostic Systems Appoints New Distributor for Italy

FORT LAUDERDALE, Fla.–(HSMN NewsFeed)–Imaging Diagnostic Systems, Inc., (OTCBB:IMDS ) announced today that Socrate Medical SRL located in Milan, Italy has been selected as a distributor for the CT Laser Mammography (CTLM®) system in Northern and Cent…
Devices, Distribution
Imaging Diagnostic Systems, Socrate Clinical SRL, CT Laser Mammography

Starch Clinical Launches Advanced Laparoscopic Hemostat

SAN JOSE, Calif., April 29 (HSMN NewsFeed) — Starch Clinical Inc (SMI), a San Jose, CA-based pharmaceutical device manufacturer, announces the introduction of its advanced PerClot(TM) Laparoscopic hemostat in the European Union and other big international mar…
Devices, Surgery
Starch Pharmaceutical, PerClot , Laparoscopic hemostat

Prospera Reports Recent Advances in Negative Pressure Wound Therapy (NPWT) Research Presented at the SAWC in Dallas

FORT WORTH, Texas–(HSMN NewsFeed)–In a general session address to attendees at the 22nd Annual Symposium on Advanced Wound Care and Wound Healing Society, Dallas, Texas, Prospera(R) Technologies, LLC announced that Christian Torbrand, MD, of Lund Univers…
Devices, Wound Care
Prospera Technologies, Negative Pressure Wound Therapy

Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

Extended Median Survival by 4.1 Months and Increased 3-Year Survival by 38 % Compared to Placebo First Active Cellular Immunotherapy for Cancer to Prolong Survival Company to Host Webcast at 5:30 pm ET CHICAGO and SEATTLE, April 28 (HSMN Ne…
Biopharmaceuticals, Oncology
Dendreon, PROVENGE, sipuleucel-T, prostate cancer

XIAFLEX(TM) for the Treatment of Dupuytren’s Contracture Receives Priority Review From the U.S. Food and Drug Administration

MALVERN, PA–Apr 28, 2009 — Auxilium Pharmaceuticals, Inc. (NasdaqGS:AUXL ), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted priority review status to its Biologic…
Biopharmaceuticals, FDA
Auxilium Pharmaceuticals, XIAFLEX, collagenase, Dupuytren’s contracture

FDA has Granted HUD (Humanitarian Use Device) Designation to ITGI’s Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts

OR AKIVA, Israel, April 28 (HSMN NewsFeed) — ITGI Lab, Ltd. (TASE: ITGI) a company engaged in research, development, manufacturing and marketing of heterologous tissue covered stents, announced that the US Food and Drug Administration (FDA) has gran…
Devices, Interventional Cardiology, FDA
ITGI Pharmaceutical, Over and Under, Aneugraft, Pericardium Covered Stent

ATS Clinical Appoints New Vice President of Marketing

MINNEAPOLIS, April 27 (HSMN NewsFeed) — ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the appointment of Michael E. Reinhardt to the job of Vice President of …
Devices, Cardiology, Surgery, Personnel
ATS Pharma